share_log

Corvus Pharma Q4 EPS $(0.14) Misses $(0.12) Estimate

Corvus Pharma Q4 EPS $(0.14) Misses $(0.12) Estimate

Corvus Pharma第四季度每股收益美元(0.14美元)未達到預期(0.12美元)
Benzinga ·  03/19 16:04

Corvus Pharma (NASDAQ:CRVS) reported quarterly losses of $(0.14) per share which missed the analyst consensus estimate of $(0.12) by 16.67 percent. This is a 33.33 percent increase over losses of $(0.21) per share from the same period last year.

Corvus Pharma(納斯達克股票代碼:CRVS)公佈的季度虧損爲每股0.14美元,比分析師普遍預期的0.12美元(0.12美元)低16.67%。這比去年同期每股虧損0.21美元(0.21美元)增長了33.33%。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論